Nurix Therapeutics, Inc. (NRIX)
25.77
-0.44
(-1.68%)
USD |
NASDAQ |
Aug 31, 16:00
25.77
0.00 (0.00%)
After-Hours: 17:35
Nurix Therapeutics Free Cash Flow (Quarterly) : -98.51M for May 31, 2026
Free Cash Flow (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -98.51M |
| February 28, 2026 | -72.96M |
| November 30, 2025 | -72.96M |
| August 31, 2025 | -60.10M |
| May 31, 2025 | -65.84M |
| February 28, 2025 | -64.57M |
| November 30, 2024 | -50.86M |
| August 31, 2024 | -44.52M |
| May 31, 2024 | -41.64M |
| February 29, 2024 | -44.84M |
| November 30, 2023 | 24.10M |
| August 31, 2023 | -43.59M |
| May 31, 2023 | -19.55M |
| February 28, 2023 | -50.73M |
| November 30, 2022 | -40.52M |
| Date | Value |
|---|---|
| August 31, 2022 | -49.73M |
| May 31, 2022 | -35.70M |
| February 28, 2022 | -46.10M |
| November 30, 2021 | -31.77M |
| August 31, 2021 | -31.84M |
| May 31, 2021 | -33.63M |
| February 28, 2021 | 7.21M |
| November 30, 2020 | -21.39M |
| August 31, 2020 | -7.811M |
| May 31, 2020 | -16.04M |
| February 29, 2020 | 40.61M |
| November 30, 2019 | -13.70M |
| August 31, 2019 | 35.88M |
| May 31, 2019 | -13.39M |
| February 28, 2019 | -9.842M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Monte Rosa Therapeutics, Inc. | -48.84M |
| Gilead Sciences, Inc. | 3.433B |
| TG Therapeutics, Inc. | 38.97M |
| Cue Biopharma, Inc. | -29.00M |
| Keros Therapeutics, Inc. | -20.58M |